- Type / Class
- Equity / Common Stock
- Shares outstanding
- 235,704,040
- Total 13F shares
- 9,228,077
- Share change
- -125,403
- Total reported value
- $45,033,000
- Price per share
- $4.88
- Number of holders
- 17
- Value change
- -$611,446
- Number of buys
- 6
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 000899104?
CUSIP 000899104 identifies ADMA - ADMA BIOLOGICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 000899104:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Aisling Capital LLC |
13F
|
Company |
1.5%
|
3,608,171
|
$18,474,000 | — | 31 Dec 2016 | |
| Biomark Capital Management Co. LLC |
13F
|
Company |
0.61%
|
1,433,304
|
$7,339,000 | — | 31 Dec 2016 | |
| Consonance Capital Management LP |
13F
|
Company |
0.54%
|
1,273,933
|
$6,523,000 | — | 31 Dec 2016 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.47%
|
1,113,293
|
$5,700,000 | — | 31 Dec 2016 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.31%
|
721,102
|
$3,692,000 | — | 31 Dec 2016 | |
| FMR LLC |
13F
|
Company |
0.18%
|
423,100
|
$2,166,000 | — | 31 Dec 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.15%
|
359,499
|
$1,841,000 | — | 31 Dec 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.06%
|
145,394
|
$744,000 | — | 31 Dec 2016 | |
| Iguana Healthcare Management, LLC |
13F
|
Company |
0.04%
|
100,000
|
$512,000 | — | 31 Dec 2016 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.04%
|
100,000
|
$512,000 | — | 31 Dec 2016 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
30,000
|
$154,000 | — | 31 Dec 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
23,282
|
$119,000 | — | 31 Dec 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.01%
|
18,213
|
$93,000 | — | 31 Dec 2016 | |
| Spark Investment Management LLC |
13F
|
Company |
0.01%
|
13,380
|
$68,000 | — | 31 Dec 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
8,237
|
$42,000 | — | 31 Dec 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
856
|
$4,000 | — | 31 Dec 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
785
|
$4,000 | — | 31 Dec 2016 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q1 2017
As of 31 Mar 2017,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,228,077 shares.
The largest 10 holders included
Aisling Capital LLC, Biomark Capital Management Co. LLC, Consonance Capital Management LP, Broadfin Capital, LLC, PERCEPTIVE ADVISORS LLC, FMR LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, Iguana Healthcare Management, LLC, and Weiss Multi-Strategy Advisers LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
17
Q1 2017 holders
17
Holder diff
0
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 Value $ | Q1 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.